Aetna Inc (AET) 118.07 $AET Aetna (AET) Approaches New

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Aetna Inc (AET) 118.07 $AET

Aetna (AET) Approaches New Upside Target of $119.71
Comtex SmarTrend(R) - Wed Aug 05, 12:31PM CDT
Aetna (NYSE:AET) has opened bullishly above the pivot of $114.84 today and has reached the first level of resistance at $117.45. Analysts will be watching for a cross of the next upside pivot targets of $119.71 and $124.57.
AET: 118.07 (+2.88)

Relocating for Retirement? Here's What You Need to Know
at The Street - Wed Aug 05, 11:28AM CDT
Relocating for retirement involves a slew of costs, aside from just hiring movers.
ANTM: 154.95 (+2.45), CIG: 2.67 (-0.12), AET: 118.07 (+2.88), HUM: 185.54 (+3.21)

Health Net Tops Q2 Earnings on Memberships, Reaffirms View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 05, 10:40AM CDT
Health Net, Inc.'s (HNT) second-quarter 2015 operating income came in at 95 cents per share. The figure exceeded the Zacks Consensus Estimate of 88 cents.
CNC: 71.46 (+0.97), ANTM: 154.95 (+2.45), AET: 118.07 (+2.88), HNT: 69.03 (+0.38)

Company News for August 05, 2015 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Wed Aug 05, 9:10AM CDT
Companies in the News are: S,CVS,AET,CAR
S: 3.15 (-0.34), CAR: 43.84 (-1.24), CVS: 111.20 (+1.24), AET: 118.07 (+2.88)

DaVita Beats Q2 Earnings Estimates, Updates 2015 Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 05, 8:45AM CDT
DaVita HealthCare Partners Inc. (DVA) reported second-quarter 2015 adjusted operating earnings of 95 cents per share that surpassed the Zacks Consensus Estimate by 1.06%.
ANTM: 154.95 (+2.45), DVA: 80.49 (+0.29), AET: 118.07 (+2.88), MOH: 77.24 (+1.84)

Aetna achieves better net income of USD731.8m for second quarter of 2015
M2 - Wed Aug 05, 5:52AM CDT
Healthcare company Aetna (NYSE:AET) stated on Tuesday that it recorded a net income of USD731.8m for the second quarter of 2015.
AET: 118.07 (+2.88)

Business Highlights
By The Associated Press - AP - Tue Aug 04, 5:03PM CDT
___
BAX: 42.13 (+1.82), DIS: 110.53 (-11.16), CVS: 111.20 (+1.24), AET: 118.07 (+2.88), UAL: 58.11 (-0.84)

After Yesterday's Rally of 1.08% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Aug 04, 3:53PM CDT
Aetna (NYSE:AET) traded in a range yesterday that spanned from a low of $112.24 to a high of $117.10. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $114.98 on volume of 4.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AET: 118.07 (+2.88)

Watch for Aetna to Potentially Pullback After Gaining 1.08% Yesterday
Comtex SmarTrend(R) - Tue Aug 04, 3:53PM CDT
Aetna (NYSE:AET) traded in a range yesterday that spanned from a low of $112.24 to a high of $117.10. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $114.98 on volume of 4.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AET: 118.07 (+2.88)

Aetna (AET) Earnings Report: Q2 2015 Conference Call Transcript
at The Street - Tue Aug 04, 2:34PM CDT
The following Aetna (AET) conference call took place on August 4, 2015, 08:30 AM ET. This is a transcript of that earnings call:
AET: 118.07 (+2.88)

Stock Recover From Session Lows; Netflix Jumps
at The Street - Tue Aug 04, 2:01PM CDT
Stocks are slightly lower on Tuesday as Apple drags and Netflix jumps.
NFLX: 123.71 (+2.56), COH: 31.73 (+0.32), S: 3.15 (-0.34), CVS: 111.20 (+1.24), AIG: 62.96 (+0.62), TWTR: 28.48 (-0.86), AET: 118.07 (+2.88), AAPL: 115.40 (+0.76)


Aetna turns in better-than-expected 2Q, hikes forecast again
By TOM MURPHY - AP - Tue Aug 04, 12:07PM CDT
Aetna's second-quarter earnings jumped 33 percent and the health insurer raised its 2015 forecast again after receiving a boost from a government business it plans to feed with a roughly $35 billion acquisition.
CI: 147.55 (+3.66), CNC: 71.46 (+0.97), ANTM: 154.95 (+2.45), CTRX: 61.47 (+0.04), UNH: 123.92 (+3.08), ANTX: 51.10 (+0.37), CCT.TO: 80.18 (+0.12), AET: 118.07 (+2.88), HNT: 69.03 (+0.38), HUM: 185.54 (+3.21)

Aetna Beats on Q2 Earnings, Misses Revenue, Ups Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 04, 10:26AM CDT
Aetna (AET) earnings of $2.05 per share came in ahead of the Zacks Consensus Estimate of $1.84 per share.
CI: 147.55 (+3.66), UNH: 123.92 (+3.08), AET: 118.07 (+2.88), HUM: 185.54 (+3.21)

Stocks Fall as Apple Slumps, Netflix Hits All-Time High
at The Street - Tue Aug 04, 10:01AM CDT
Stocks are lower on Tuesday as Apple slips further into correction territory and Netflix hits an all-time high.
NFLX: 123.71 (+2.56), COH: 31.73 (+0.32), S: 3.15 (-0.34), CVS: 111.20 (+1.24), TM: 128.31 (-1.54), AIG: 62.96 (+0.62), TWTR: 28.48 (-0.86), AET: 118.07 (+2.88), AAPL: 115.40 (+0.76)

Aetna (AET) Stock Rises in Pre-Market Trading on Earnings Results
at The Street - Tue Aug 04, 8:21AM CDT
Aetna (AET) stock is increasing in pre-market trading as the company’s 2015 second quarter earnings per share results surpass estimates.
AET: 118.07 (+2.88)

Stock Futures Mixed; Apple in Correction Territory
at The Street - Tue Aug 04, 8:15AM CDT
Stock futures are mixed on Tuesday morning after a bumpy session a day earlier and as investors digest a rush of earnings from Coach to CVS Health.
COH: 31.73 (+0.32), S: 3.15 (-0.34), CVS: 111.20 (+1.24), TM: 128.31 (-1.54), AIG: 62.96 (+0.62), TWTR: 28.48 (-0.86), AET: 118.07 (+2.88), AAPL: 115.40 (+0.76)

Stocks Set For Lower Start; Regeneron Jumps On Earnings
at Investor's Business Daily - Tue Aug 04, 8:01AM CDT
Stock futures were on pace for a weak start Tuesday, despite a rebound in oil prices. Nasdaq 100 futures dropped 10 points vs. fair value, and S&P 500 futures lost 4 points. Futures on the Dow Jones industrial average slumped 28 points. The major...
ATVI: 28.71 (+3.04), FSLR: 51.92 (+7.42), BOOT: 27.39 (-5.76), CYH: 56.82 (-2.37), DIS: 110.53 (-11.16), ETSY: 13.78 (-5.45), CHUY: 34.22 (+6.39), EPAM: 70.14 (-2.85), AET: 118.07 (+2.88), CERN: 67.30 (-3.02), REGN: 592.40 (+11.46)

Aetna Q2 Earnings Beat Estimates, Guidance Raised - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 04, 6:44AM CDT
Aetna Q2 Earnings Beat Estimates, Guidance Raised
AET: 118.07 (+2.88)

Aetna Reports Second-Quarter 2015 Results
Business Wire - Tue Aug 04, 5:00AM CDT
--Net income (2) per share was $2.08 for the second quarter of 2015
AET: 118.07 (+2.88)

Aetna, CVS, Disney, Sprint Earnings on Tap for Tuesday
at The Street - Mon Aug 03, 7:15PM CDT
Also, Papa John's and Charter earnings will be released along with important economic data.
ATVI: 28.71 (+3.04), COH: 31.73 (+0.32), S: 3.15 (-0.34), PZZA: 71.45 (-4.16), CHTR: 188.55 (-2.95), DIS: 110.53 (-11.16), CVS: 111.20 (+1.24), AET: 118.07 (+2.88)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

China's Tech Success Echoes in Global Living Rooms

Updated Category News Views 4

A New Player in Global Tech If you've been sleeping on China's tech scene, it's time to wake up. Moonshot AI just launched Kimi K3, the largest open-source model by parameters we've seen, a significant leap in artificial intelligence that's catching even the eyes of folks who hardly touch technology—like retirees in Italy. Rapid AI Advancements China's story isn't about...

Continue Reading
Xi Jinping Thought: A Bold Prospect for Future Governance

Updated Category News Views 5

107 years in the game, and the Communist Party of China (CPC) isn't showing any signs of slowing. With their recent conference in Beijing focusing on Xi Jinping Thought on Party Building, it’s clear they’ve got their eyes on the future, not just resting on past laurels. This Xi Jinping Thought is about a thorough self-improvement plan for the Party, a clear strategy...

Continue Reading
Why Liver Nurture Taps into Health Sector Trends

Updated Category News Views 5

Liver Wellness: A Sector on the Rise Remember when everyone was all about heart health and cholesterol levels? Seems like these days, folks have shifted their focus a bit south—right to the liver. It's no surprise, really. With our modern diet and lifestyle choices squeezing the life out of this hard-working organ, people are on the hunt for ways to give it the TLC it...

Continue Reading
Flying Car Regulatory Sandbox Begins in UAE

Updated Category News Views 7

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Continue Reading
Papa John's Faces Class Action Over Misleading Info

Updated Category News Views 5

Trouble Brewing for Papa John's Investors Rolling the dice in the stock market sometimes feels like playing the lottery, doesn't it? This time around, it's Papa John's (NASDAQ: PZZA) serving up a slice of turmoil for its investors. The pizza chain's got itself tangled in a class-action lawsuit, and it's the shareholders who're left with a bitter taste. Investors Cry Foul...

Continue Reading
Chery Auto's Bold Green Tech Showcase at 2026 Summit

Updated Category News Views 3

Chery Auto Puts Eco Tech at Front and Center You know, Chery Auto isn't just manufacturing cars anymore—it's shaping an entire lifestyle. For the uninitiated, they’re calling in everyone worth knowing to their headquarters in Wuhu, China, come October 18 through 24. The 2026 Chery International User Summit is kind of a big deal this year with nearly 20 new green...

Continue Reading
Quay Dominates 2026 Sunglasses Review for Variety

Updated Category News Views 4

Sunglasses Designed for Every Face Type When it comes to picking the right pair of shades, face shape is only part of the equation. Expert Consumers just dropped their 2026 verdict, spotlighting Quay as the go-to brand for those wider faces, tricky nose bridges, and the noggins that run a tad larger than average. Forget what you heard about one-size-fits-all. This...

Continue Reading
Insta360 Expands with Times Square Flagship Store

Updated Category News Views 6

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...

Continue Reading
2026 Lantern Festival Shines in Kunshan Amid Tensions

Updated Category News Views 4

Lanterns Illuminate Cross-Strait Relations Under the shadow of geopolitical tensions, the 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival kicked off with a splash on September 16. Held in Kunshan, Suzhou, this cultural festival offers a rare glimpse of cooperation and shared cultural celebration across the Taiwan Strait. Through lantern displays, art exhibitions,...

Continue Reading
Tragedy Highlights Need for E-bike Safety Overhaul

Updated Category News Views 5

A Dire Wake-Up Call in the East Village We're staring hard at a heartbreaking mess in the East Village. A 15-year-old girl lost her life while riding an electric Citi Bike, hit by an industrial truck. Let's not dance around it—this is a gut punch, the kind you never want to ever hear about, and one that comes with a bitter flavor of 'what if?' Age Verification: A...

Continue Reading

Top 5 Most Recently Viewed Articles

Investor Alert: Join BioAge Labs, Inc. Securities Lawsuit Now

Updated Category News Views 247

Understanding the BioAge Labs, Inc. Securities Lawsuit In an important update for investors, the DJS Law Group is handling a significant class action lawsuit against BioAge Labs, Inc. This case revolves around allegations of violations of federal securities laws by the company, which trades under the ticker NASDAQ: BIOA. Eligibility for Shareholders Shareholders who...

Continue Reading
Rocket Doctor AI Inc.: A Major Leap in Digital Health Technology

Updated Category News Views 181

Rocket Doctor AI Inc.: Embracing a New Identity Rocket Doctor AI Inc. is set to embark on an exciting new chapter as it transitions from Treatment.com AI Inc. This rebranding not only marks a change in the company's name but also reflects its commitment to evolving within the rapidly advancing digital health sector. New Trading Symbol and Focus As part of rebranding,...

Continue Reading
Innovative Clinical Trial for HemaXellerate™ by Regen BioPharma

Updated Category News Views 392

Regen BioPharma's Advancements with HemaXellerate™ Regen BioPharma, Inc. is stepping into a pivotal role in the biotechnology sector with its promising Phase 1 clinical trial for HemaXellerate™, an innovative treatment designed to address aplastic anemia among other severe health issues. This trial, already greenlit by the FDA, is setting the stage for transformative...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 7

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Legal Developments for SRIVARU Holding Limited and Share Implications

Updated Category News Views 537

Understanding the Legal Situation of SRIVARU Holding Limited SRIVARU Holding Limited (OTC: SVUHF) is currently navigating a significant legal challenge from Sabby Volatility Warrant Master Fund Ltd. The claim has been lodged in the Supreme Court of the State of New York, highlighting concerns surrounding warrant exercises and share valuations. This article aims to clarify...

Continue Reading